Login / Signup

A third generation PSMA-targeted agent [ 211 At]YF2: Synthesis and in vivo evaluation.

Yutian FengRebecca L MeshawSean W FinchYongxiang ZhengIl MinnGanesan VaidyanathanMartin G PomperMichael R Zalutsky
Published in: Nuclear medicine and biology (2024)
At]YF2 are under way.
Keyphrases
  • pet ct
  • pet imaging
  • cancer therapy
  • drug delivery
  • clinical evaluation